✦ LIBER ✦

A phase II study of GM-CSF and rIFN-γ1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer

✍ Scribed by Kathleen M. Schmeler; Saroj Vadhan-Raj; Pedro T. Ramirez; Sachin M. Apte; Lorenzo Cohen; Roland L. Bassett; Revathy B. Iyer; Judith K. Wolf; Charles L. Levenback; David M. Gershenson; Ralph S. Freedman

Book ID: 113961975
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 402 KB
Volume: 113
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2009.02.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of pemetrexed and carbopl

Phase II trial of pemetrexed and carboplatin in platinum-sensitive recurrent ovarian, fallopian tube, and primary peritoneal cancer

✍ Van Arsdale, A.; Einstein, M.H.; Brewer, M.A.; Timmins, P.F.; Wright, J.D.; Leis 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 62 KB

A phase II clinical trial of pegylated l

A phase II clinical trial of pegylated liposomal doxorubicin and carboplatin plus bevacizumab in patients with platinum-sensitive recurrent ovarian, fallopian tube, or primary peritoneal cancer

✍ Marcela G. del Carmen; John Micha; Laurie Small; Daron G. Street; Anil Londhe; T 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 254 KB

A phase II study of cetuximab/paclitaxel

A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer

✍ Jason Konner; Russell J. Schilder; Felicia A. DeRosa; Scott R. Gerst; William P. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 226 KB

A phase II study of gemcitabine, carbopl

A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian cancer

✍ E. Eisenhauer; V. Zanagnolo; D. Cohn; R. Salani; D. O'Malley; G. Sutton; B. Cobb 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 134 KB

A phase II study of gemcitabine, carbopl

A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian cancer

✍ Eisenhauer, Eric L.; Zanagnolo, Vanna; Cohn, David E.; Salani, Ritu; O'Malley, D 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 430 KB

Independent radiologic review of OCEANS,

Independent radiologic review of OCEANS, a phase III trial of carboplatin, gemcitabine, and bevacizumab or placebo for the treatment of platinum-sensitive, recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer

✍ C. Aghajanian; S. Makhija; T. Rutherford; S. Sharma; L. Nycum; M. Sovak; H. Nguy 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 136 KB